Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rapid neuroplasticity changes and response to intravenous ketamine: a randomized controlled trial in treatment-resistant depression
Jared M. Kopelman, Timothy A. Keller, Benjamin Panny, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Alcohol Use Disorder and Chronic Pain: An Overlooked Epidemic
João P. De Aquino, Matthew E. Sloan, Julio C. Nunes, et al.
American Journal of Psychiatry (2024) Vol. 181, Iss. 5, pp. 391-402
Closed Access | Times Cited: 9
An integrative view on the cell-type-specific mechanisms of ketamine's antidepressant actions
Vern Lewis, Gareth M. Rurak, Natalina Salmaso, et al.
Trends in Neurosciences (2024) Vol. 47, Iss. 3, pp. 195-208
Open Access | Times Cited: 6
Experiences of Awe Mediate Ketamine’s Antidepressant Effects: Findings From a Randomized Controlled Trial in Treatment-Resistant Depression
Julia Aepfelbacher, Benjamin Panny, Rebecca B. Price
Biological Psychiatry Global Open Science (2024) Vol. 4, Iss. 4, pp. 100316-100316
Open Access | Times Cited: 4
Demographic and clinical predictors of response and remission in the treatment of major depressive disorder with ketamine and esketamine: A systematic review
Juliana Lima Constantino, Michael Godschalk, Jens H. van Dalfsen, et al.
Psychiatry Research (2025) Vol. 345, pp. 116355-116355
Open Access
Wirkmechanismen antidepressiver Pharmakotherapie: Gehirn und Psyche – Körper und Umwelt
Moritz Spangemacher, Jonathan Reinwald, Hana Adolphi, et al.
Der Nervenarzt (2025)
Open Access
Ketamine and Ketamine-Assisted Psychotherapy for Psychiatric and Existential Distress in Patients with Serious Medical Illness: A Narrative Review
Roxanne Sholevar, William Kromka, Yvan Beaussant
Journal of Palliative Medicine (2025)
Closed Access
Hippocampal and parahippocampal volume and function predict antidepressant response in patients with major depression: A multimodal neuroimaging study
Marco Paolini, Y. Harrington, Federica Colombo, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 11, pp. 1070-1081
Open Access | Times Cited: 8
A review of diffusion MRI in mood disorders: mechanisms and predictors of treatment response
Noor Al‐Sharif, Artemis Zavaliangos‐Petropulu, Katherine L. Narr
Neuropsychopharmacology (2024) Vol. 50, Iss. 1, pp. 211-229
Closed Access | Times Cited: 2
Baseline monocyte count predicts symptom improvement during intravenous ketamine therapy in treatment-resistant depression: a single-arm open-label observational study
Bruno Pedraz‐Petrozzi, Moritz Spangemacher, Anton Deicher, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
The therapeutic potential of traditional Chinese medicine in depression: focused on the modulation of neuroplasticity
Shimeng Lv, Ni Yang, Yitong Lu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Psychopharmacological Approaches for Neural Plasticity and Neurogenesis in Major Depressive Disorders
Dina Matar, Aya Serhan, Sabah El Bilani, et al.
Advances in experimental medicine and biology (2024), pp. 27-48
Closed Access | Times Cited: 2
Multimodal brain-derived subtypes of Major depressive disorder differentiate patients for anergic symptoms, immune-inflammatory markers, history of childhood trauma and treatment-resistance
F. Colombo, Federico Calesella, Beatrice Bravi, et al.
European Neuropsychopharmacology (2024) Vol. 85, pp. 45-57
Closed Access | Times Cited: 1
Shared effects of electroconvulsive shocks and ketamine on neuroplasticity: A systematic review of animal models of depression
Jesca E. De Jager, Rutger Boesjes, Gijs H.J. Roelandt, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 164, pp. 105796-105796
Closed Access | Times Cited: 1
Transient peripheral blood transcriptomic response to ketamine treatment in children with ADNP syndrome
Ariela S. Buxbaum Grice, Laura Sloofman, Tess Levy, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Pharmacotherapeutic strategies for the treatment of anorexia nervosa – novel targets to break a vicious cycle
Millie C. Kirchberg, Claire K. Pinson, Guido Frank
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 17, pp. 2253-2265
Open Access | Times Cited: 1
Effects of psychoplastogens on blood levels of brain-derived neurotrophic factor (BDNF) in humans: a systematic review and meta-analysis
Abigail E. Calder, Adrian Hase, Gregor Hasler
Molecular Psychiatry (2024)
Open Access | Times Cited: 1
Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review
Simone Pardossi, Andrea Fagiolini, Alessandro Cuomo
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13098-13098
Open Access | Times Cited: 1
Storm on predictive brain: A neurocomputational account of ketamine antidepressant effect
Hugo Bottemanne, Lucie Berkovitch, Christophe Gauld, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 154, pp. 105410-105410
Open Access | Times Cited: 4
Merazin hydrate produces rapid antidepressant effects by activating CaMKII to promote neuronal activities and proliferation in hippocampus
Ziwei Gao, Chao Lu, Yaping Zhu, et al.
Brain Research (2023) Vol. 1822, pp. 148665-148665
Closed Access | Times Cited: 4
Psychedelics and neural plasticity
Rachael L. Sumner, Kacper Łukasiewicz
BMC Neuroscience (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Basic aspects of ketamine therapy for treatment-resistant depression - a review paper
Weronika Szafrańska, Dominika Poborowska, Tomasz Gańko, et al.
Quality in Sport (2024) Vol. 19, pp. 53331-53331
Open Access
How Do People Who Undergo Ketamine Treatment for a Psychiatric Problem Subjectively Experience This Intervention? A Meta‐Synthesis of Qualitative Studies
Melanie Trimmel, Antonia Renner, Alexander Kaltenboeck
International Journal of Mental Health Nursing (2024)
Open Access
The Impact of Intravenous Ketamine on Attentional Bias: Probing Mechanisms of Rapid-Acting Antidepressant Effects Across Two Clinical Studies
Mary L. Woody, Rebecca Rohac, I. S. Cooper, et al.
Biological Psychiatry (2024)
Open Access
MRI in CNS Drug Development
Mitul A. Mehta
(2024), pp. 243-259
Closed Access
O USO DA CETAMINA/ESCETAMINA NO TRANSTORNO DEPRESSIVO MAIOR
Juliana Celga de Mendonça, RAUL MALINI LOUVEM, BRENDA MARIA FOLLI RECLA, et al.
Editora Pasteur eBooks (2024), pp. 109-114
Open Access
Page 1 - Next Page

Scroll to top